Fifth Third Wealth Advisors
DGX icon

Fifth Third Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Fifth Third Wealth Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.39M Buy
5,977
+2,408
+67% +$557K 0.04% 257
2026
Q2 		$756K Buy
+3,569
New +$700K 0.02% 364
2025
Q4 		– Sell
-1,103
Closed -$210K – 805
2025
Q3 		$210K Buy
+1,103
New +$196K 0.01% 726

Other funds holding DGX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Conning Inc
Conning Inc Hartford, Connecticut $3.25B AUM 18.91% 1-Year Est. Return
Braun Stacey Associates
Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return
Willis Investment Counsel
Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return
Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Moran Wealth Management
Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return
Boston Common Asset Management
Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return

Fifth Third Wealth Advisors's DGX Position: Q3 2026 in Review

Fifth Third Wealth Advisors increased its Quest Diagnostics (DGX) stake by 67% in Q3 2026, buying an estimated $557K and bringing the position to 5,977 shares worth $1.39M. The position accounts for 0.04% of the portfolio, ranked #257.

Fifth Third Wealth Advisors first reported a position in DGX in Q3 2025 and has held it in 3 quarters since. 384 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Fifth Third Wealth Advisors held 5,977 shares of Quest Diagnostics worth $1.39M as of Q3 2026.
  • Fifth Third Wealth Advisors bought 2,408 Quest Diagnostics shares in Q3 2026, an estimated $557K.
  • Quest Diagnostics made up 0.04% of Fifth Third Wealth Advisors's portfolio in Q3 2026, its #257 holding.
  • Fifth Third Wealth Advisors first reported a position in Quest Diagnostics in Q3 2025 and has held it in 3 quarters since.
  • 384 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.